UMEM Educational Pearls - Pediatrics

Title: Otitis Media (submitted by Ari Kestler, MD)

Category: Pediatrics

Keywords: antibiotics, wait and see (PubMed Search)

Posted: 4/19/2013 by Mimi Lu, MD
Click here to contact Mimi Lu, MD

2013 AAP AOM Guidelines UPDATE

 
-AAP released a new clinical practice guideline for diagnosis and management of acute otitis media (AOM).
 
Key Action Statements:
 
Diagnosis if presence of middle ear effusion and
(1) moderate to severe bulging of tympanic membrane (TM) or new otorrhea or
(2) mild bulging of TM and recent ear pain or intense erythema of TM
 
Treatment options:
  • Severe unilateral or bilateral AOM (>6mo): give antibiotics.  Severe AOM is defined as fever >102.2 (39 C), moderate/severe otalgia, or symptoms >48h.
  • Nonsevere unilateral AOM (6-23 months): Advise the parents to consider a period of close observation and follow up (24-72h).  If the childs clinical status deteriorates give antibiotics.
  • Nonsevere bilateral AOM (6-23 months): give antibiotics.
  • Nonsevere unilateral or bilateral AOM (>24 months): Advise the parents to consider a period of close observation and follow up (24-72h).  If the childs clinical status deteriorates, give antibiotics.
 
 
Reference: Pediatrics Vol. 131 No. 3 March 1, 2013


Title: Conjunctivitis

Category: Pediatrics

Keywords: Conjunctivitis (PubMed Search)

Posted: 4/5/2013 by Jenny Guyther, MD
Click here to contact Jenny Guyther, MD

Children frequently present with "pink eye" to the ED.  When they do, parents often expect antibiotics.  How many of these kids actually need them?  Previous studies have shown approximately 54% of acute conjunctivitis was bacterial, but antibiotics were prescribed in 80-95% of cases.

A prospective study in a suburban children's hospital published in 2007, showed that 87% of the cases during the study period were bacterial.  The most common type of bacteria was nontypeable H. influenza followed by S. pneumoniae.

Topical antibiotic treatment has been shown to improve remission rates by 6-10 days.

Show References



You have diagnosed an infant or child with pneumonia.  How do you decide if they need admission?

The Pediatric Infectious Disease Society and the British Thoracic Society each have guidelines from 2011 to help with this decision.

 The Pediatric Infectious Disease Society recommend inpatient therapy for the following
1) oxygen saturation <90%
2) infants less than 3-6 months of age with bacterial infection being the likely etiology
3) pneumonia from suspected or documented virulent pathogen such as CA-MRSA
4) children in whom home care is questionable, outpatient follow-up is not available or who cannot comply with outpatient therapy
 
The British Thoracic Society identify risk factors likely to require hospitalization:
1) oxygen saturation <92%
2) respiratory rate > 70 breaths/min (>50 breaths/min in older children)
3) significant tachycardia for level of fever
4) prolonged capillary refill time > 2 seconds
5) breathing difficulty
6) intermittent apnea or grunting
7) not feeding or signs of dehydration
8) chronic medical conditions/comorbidities
 
References:
"The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines bythe Pediatric Infectious Diseases Society and the Infectious Diseases Society of America"
http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/2011%20CAP%20in%20Children.pdf
 
"Guidelines for the management of community acquired pneumonia in children: update 2011" BTS
http://www.brit-thoracic.org.uk/Portals/0/Guidelines/Pneumonia/CAP%20children%20October%202011.pdf


In children, it is important to consider the maximum doses of local anesthetics when performing a laceration repair or painful procedure like abscess drainage. If there are multiple lacerations, or large lacerations, it may be possible to exceed those doses if one is not careful.

 

Max doses of common anesthetics

  • Lidocaine WITHOUT epinephrine – 4 mg/kg (0.4 mL/kg of 1% lidocaine)
  • Lidocaine WITH epinephrine – 7 mg/kg (0.7 mL/kg of 1% lidocaine)  
  • Bupivicaine WITHOUT epinephrine – 2 mg/kg (0.8 mL/kg of 0.25% bupivicaine)
  • Bupivicaine WITH epinephrine – 3 mg/kg (1.2 mL/kg of 0.25% bupivicaine)

 

For example, in a 20 kg child (an average 5-6 year old), the maximum doses would be:

  • Lidocaine 1% - 8 ml
  • Lidocaine 1% with epi – 14 ml
  • Lidocaine 2% - 4 ml
  • Bupivicaine 0.25% - 16 ml
  • Bupivicaine 0.25% with epi - 24 ml

  

Pearls:

  • For added safety, some advocate not exceeding 80% of the max dose in children < 8 years of age
  • Higher concentration of lidocaine beyond 1% does not improve the time of onset or duration of action and may increases the risk of toxicity
  • The addition of epinephrine increases the maximum dose and duration of action, but may be more painful during infiltration
  • If the repair requires large amount of local anesthetic, consider doing an regional block


Title: Pediatric UTI (Age 2 - 24 Months)

Category: Pediatrics

Keywords: UTI, urinary tract infection (PubMed Search)

Posted: 3/8/2013 by Lauren Rice, MD (Updated: 11/22/2024)
Click here to contact Lauren Rice, MD

 

--The diagnosis and treatment of pediatric urinary tract infections (UTIs) can be broken down into different age groups. The AAP has recently updated its recommendations for children age 2 - 24 months.

--In ill-appearing febrile infants age 2 – 24 months, who require early initiation of antibiotics, clinicians should obtain urinalysis and urine culture by catheterization or suprapubic aspiration prior to administration of the first dose of antibiotics.

--Key components of diagnosing a UTI include: urinalysis with the presence of pyuria (>10 WBCs per µL) and bacteriuria. The ultimate diagnosis relies on identification of >50,000 CFUs per mL of a single urinary pathogen in culture.

--Treatment of most UTIs in well appearing infants 2-24 months can be done with oral antibiotics for a course of 7-14 days. Common antibiotics used include: amoxicillin-clavulanate, trimethoprim-sulfamethoxazole, or cephalosporins (cefpodoxime, cefixime) based on local patterns of susceptibility.

--Febrile infants with UTIs should undergo renal and bladder ultrasound (RBUS) to evaluate the renal parenchyma and identify complications of UTI in children who are not responding to treatment within 48 hours.

--Voiding cystourethrography (VCUG) to diagnose vesicoureteral reflux (VUR) as a cause of UTI should not be obtained routinely, but only in children with abnormal RBUS or with recurrent febrile UTIs.

 

Show References



Management of the patient with intracranial hypertension represents one of the most challenging situations the emergency physician faces. Doing so in a community setting when the patient is a child is even more daunting. But devising therapies that can safely be given while the patient is being transferred to a tertiary center for definitive therapy is truly cringe-inducing. 
 
Fortunately, a recent study suggests that 3% saline fits this bill nicely. Given the risk of vasconstriction with hyperventilation and the risk of hypovolemia with mannitol, hypertonic saline has gained has emerged as beneficial therapy when trying to decrease intracranial pressure (ICP) in both children and adults. 
 
In late 2011, the Loma Linda University Medical Center published a retrospective analysis of their experience using 3% saline during transport of children at risk of elevated ICPs. While they found the expected rise in electrolytes such as sodium, chloride and bicarbonate, importantly they found no adverse effects (such as "local effects, renal abnormalities or central pontine myelinolysis") related to the administration of hypertonic saline, even though 96% of patients received the infusion through a peripheral line.
 
Bottom line: hypertonic saline appears to be a viable and safe option for use as therapy to decrease ICH during transport of children at risk for intracranial hypertension.
 
 
Reference:

Luu JL, Wendtland CL, Gross MF, et al. Three percent saline administration during pediatric critical care transport. Ped Emerg Care 2011;27(12):1113-1117



This winter season has brought a rise in influenza and RSV activity in Maryland and in many parts of the country. It is also important to remember other potentially lethal infections that are prevalent in the winter and early spring months, such as Neisseria meningitidis. In fact, a recent study2 showed a potential increase in meningococcal disease when influenza and RSV activity is high.

What:
Encapsulated, gram-negative diplococcus
Where:
Found in nasopharyngeal secretions, carrier rates 2-30% in normal populations
Who:
Age of incidence has 2 peaks: children < 2 years old, teens 15-19 years old
Young adults who live in shared housing, such as college dorms and military recruits

Clinical Presentation:
Early non-specific symptoms of URI, fever, malaise, myalgias
Meningitis: non-specific prodrome + headache, stiff neck (not found in younger children who often present atypically with irritability and/or vomiting)
Meningococcemia: above symptoms + hypotension + petechial rash (>60% of patients)

Treatment:
Early (!) antibiotics: 3rd generation cephalosporins (<3mo: cefotaxime; older infants, children, and teens: ceftriaxone); PCN G is antibiotic of choice for susceptible isolates
Early and aggressive management of shock

Prevention:
Tetravalent vaccine, MCV4 (Menactra, Menveo), available for serogroups A, C, Y and W-135 is given routinely at age 11-12 years old with an additional booster at 16-17 years old. MCV4 does not protect against serogroup B which accounts for 30% of infections.

 

Show References



Title: Swallowed foreign body? (submitted by John Greenwood, MD)

Category: Pediatrics

Keywords: magnets, bowel perforation, ischemic necrosis, ingestion (PubMed Search)

Posted: 11/30/2012 by Mimi Lu, MD (Updated: 1/18/2013)
Click here to contact Mimi Lu, MD

Question

Patient:  A 10 year old female is brought to the ED after swallowing 2 beads (see image).  Based on the findings, what are your concerns and what is the disposition?

Show Answer



  • CDC recommends pediatric influenza antiviral treatment for those at higher risk for influenza complications, and include the following:
  1. less than 2 years of age;
  2. chronic diseases including: pulmonary (ie asthma), cardiovascular (except hypertension alone), renal, hepatic, hematologic (ie sickle cell disease), metabolic (ie diabetes), neurologic/neurodevelopmental (ie cerebral palsy, epilepsy), and intellectual disability (ie mental retardation)
  3. immunosuppression (ie HIV)
  4. less than 19 years of age and on chronic aspirin treatment;
  5. morbid obesity (BMI>40)
  • adamantanes (amantadine and rimantadine) should not be used due to high levels of resistance to influenza A
  • neuraminadase inhibitors (oseltamivir and zanamivir) should be started within 48 hours of illness onset to reduce the duration and severity of disease
  • oseltamivir can be used in children as young as 2 weeks of age at a dose of 3mg/kg twice daily for 5 days.

 

Show References



Title: Rotavirus

Category: Pediatrics

Posted: 1/4/2013 by Lauren Rice, MD (Updated: 11/22/2024)
Click here to contact Lauren Rice, MD

 

Rotavirus is the leading cause of gastroenteritis worldwide and a leading cause of infant death in the developing world.

95% of U.S. children have had a rotavirus infection by the age of 5 years.

Most cases occur in late winter and early spring.

Route of transmission is mostly fecal-oral but may be airborne in cooler months.

Most common presenting signs and symptoms include fever (1/3 of cases), vomiting (in the first 1-2 days), and diarrhea (copious, watery, lasting 5-21 days).

Diagnosis is largely based on clinical manifestations, but antigen assays are available and may be useful in patients with extraintestinal complications, such as hepatitis, pneumonitis, or encephalopathy.

Treatment is largely supportive with efforts to maintain hydration.

Prevention is key to disease control and accomplished with good hand hygiene and widespread vaccination.

Newly implemented vaccine programs worldwide have proven to be effective in decreasing hospitalizations and deaths in developing countries.

Show References



An 18-months old presents with classic symptoms of bronchiolitis.  A trial of Albuterol does not show any objective improvement. What are your other options?
- Nebulized epinephrine: 0.9mg/kg for racemic epi or 0.03 mL/kg of the 2.25% solution (diluted in 3mL) - improves oxygen saturation and respiratory rate, but does not affect admission rates
- Hypertonic saline (3%): decreases hospital length of stay and improves clinical scores, possibly by decreasing airway edema and mucus plugging
- Nasal CPAP: improves ventilation in children with bronchiolitis and hypercapnia
- Heliox: decreases respiratory distress, by reducing gaseous flow resistance and improving alveolar ventilation

Interventions that have shown no benefit and are not recommended:
- Anticholinergics
- oral and/or inhaled corticosteroids


Reference:
Joesph, M. Evidence-Based Assessment and Management of Acute Bronchiolitis in the Emergency Department. Pediatric Emergency Medicine Practice 2011; 8(3)


Title: Nasal foreign body removal

Category: Pediatrics

Posted: 12/15/2012 by Mimi Lu, MD (Updated: 12/21/2012)
Click here to contact Mimi Lu, MD

Parents bring in their child who placed a bead, seed, or other object up her nose.  What do you do?  Who should you call?

Research suggests that a decades-old home remedy (of sorts) known as the “mother’s kiss” may do the trick for children 1-8 years of age. It’s also much less invasive or frightening than some of the tools and techniques used in emergency departments with a success rate approaching 60%

What Is the “Mother’s Kiss”?

First described in 1965, here’s how the mother’s kiss technique works:

  • The parent or caretaker places their mouth over their child’s mouth while holding the unaffected nostril closed with one finger.
  • The parent or caretaker blows into the child’s mouth.
  • The forceful breath may force the object out (warning: may want to wear protective covering as other things have been known to fly out as well!)

 

Reference:
Cook S, Burton M, Glasziou P. Efficacy and safety of the "mother's kiss" technique: a systematic review of case reports and case series. CMAJ.2012 Nov 20;184(17):E904-12. doi: 10.1503/cmaj.111864. Epub 2012 Oct 15.

 



Epidemiology:

Trampoline injuries doubled between 1991 and 1996, increasing from 39,000 injuries per year to more then 83,000 injuries per year.  Injury rates and trampoline sales peaked in 2004 and have been decreasing since; however, hospitalization rates are still between 3% and 14%.

Risk Factors:

¾ of injuries occur when multiple people are on the trampoline at once

Smaller participants were 14x more likely to be injured then their heavier playmates

Falls account for 27-39% of all injuries

Springs and frames account for 20% of injuries

Up to ½ of injuries occur despite adult supervision

Injury types:

Lower extremity injuries are more common than upper extremity

Head and neck injuries accounted for 10-17% of trampoline injuries

Unique Injuries:

Proximal tibial fractures

Manubriosternal dislocations and sternal injuries

Vertebral artery dissection

Atlanto-axial subluxation

Show References



Title: Fever and neck pain (submitted by Connor Lundy, MD)

Category: Pediatrics

Keywords: meningitis, neck pain, retropharyngeal abscess (PubMed Search)

Posted: 11/16/2012 by Mimi Lu, MD
Click here to contact Mimi Lu, MD

Question

A 1 year old gets sent from their pediatrician’s office for rule out meningitis. They presented with fever for 2 days and neck rigidity. Your LP results are normal. What additional test should you consider?
 

Show Answer



Conventional pediatric nasal cannula can safely deliver up to 4 lpm but are limited by cooling and drying of the airway. This leads to decreased airway patency, nasal mucosal injury, bleeding and possibly increase in coagulase negative staph infections.

HFNC delivers flow up to 40 lpm with 95-100% relative humidity at a controlled temperature. In infants, the initial flow rate is set between 2-4 lpm and can be increased to 8 lpm. Older children and can be started at 10 lpm and increased as high as 40 lpm. Oxygen is also adjustable.

Studies have shown improved comfort, respiratory rate and oxygenation compared to nasal CPAP.

Show References



- If child is <6 months think: laryngomalacia and if >6y-3y/o think croup
- The differential of child with stridor <6m:
Ø  laryngomalacia
Ø  vocal cord paralysis
Ø  subglottic stenosis
Ø  vascular ring structures
- Other causes of stridor: tracheitis, epiglottitis, trauma, foreign body, deep neck space infection
- Tips for the treatment of croup:
Ø  Dexmethasone is superior to prednisolone. Start dexmethasone  at 0.15-0.6 mgkg. Typically one time dosing is sufficient. PO/IM forms are considered equivalent.
Ø  A 2011 Cochrane review found no difference in the type of nebulized epinephrine used.
Ø  If regular epinephrine dosing is 0.5 ml/kg of 1:1000. If 2.25% racemic epinephrine, give 0.05 ml/kg.
 
http://www.youtube.com/watch?v=1Enq2BvX9aw&feature=fvwrel
 
References
Donaldson D, et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial. Acad Emerg Med. 2003 Jan;10(1):16-21.
Leung AKC, Cho H. Diagnosis of stridor in children. Am Fam Physician. 1999 Nov 15;60(8):2289-2296.
Sparrow A, Geelohoed G.  Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Arch Dis Child. 2006 Jul;91(7):580-3.


Title: Pediatric Cerebral Edema in DKA

Category: Pediatrics

Posted: 10/12/2012 by Rose Chasm, MD (Updated: 11/22/2024)
Click here to contact Rose Chasm, MD

  • approximately 1% of children in DKA have some degree of cerebral edema, and up to 25% of them may die
  • known risk factors include the following:
  1. younger children (especially <5 years)
  2. new onset or newly diagnosed
  3. increased BUN at presentation
  4. severity of acidosis at presentation
  5. bicarbonate therapy use
  6. failure of sodium to improve following therapy

Show References



Title: Vaccines in children less then 1 year

Category: Pediatrics

Keywords: Vaccines (PubMed Search)

Posted: 10/5/2012 by Jenny Guyther, MD (Updated: 11/22/2024)
Click here to contact Jenny Guyther, MD

We often ask our pediatric patients if there vaccines are up to date, but what does this mean?

Hepatitis B: birth, 2 and 6 months

Diphtheria/Tetanus and Acellular Pertussis: 2, 4 and 6 months

Pneumococcal vaccine: 2, 4 and 6 months

Haemophilus influenzae B : 2, 4 and 6 months

Polio: 2, 4 and 6 months

Rotavirus: 2 and 4 months or 2, 4 and 6 months depending on the brand. 

Influenza: 6 months and older

Children less than 8 years old should receive 2 doses of flu vaccine at least 4 weeks apart during the first flu season that they are immunized.  Children older than 2 years are eligible for the nasal vaccine if they do not have asthma, wheezing in the past 12 months or other medical conditions that predispose them to flu complications.

To see the full vaccine schedule including exact time frames between doses and catch up schedules, see: http://www.cdc.gov/vaccines/schedules/downloads/child/0-6yrs-schedule-pr.pdf

Show References



The incidence of pediatric syncope is common with 15%-25% of children and adolescents experiencing at least one episode of syncope before adulthood. Incidence peaks between the ages of 15 and 19 years for both sexes.

Although most causes of pediatric syncope are benign, an appropriate evaluation must be performed to exclude rare life-threatening disorders. In contrast to adults, vasodepressor syncope (also known as vasovagal) is the most frequent cause of pediatric syncope (61%–80%).  Cardiac disorders only represent 2% to 6% of pediatric cases but account for 85% of sudden death in children and adolescent athletes.  17% of young athletes with sudden death have a history of syncope.

Key features on history and physical examination for identifying high-risk patients include exercise-related symptoms, a family history of sudden death, a history of cardiac disease, an abnormal cardiac examination, or an abnormal ECG.

Pediatric Dysrhythmias that can cause syncope in children:
- Congenital long QT
- Brugada syndrome
- Catecholaminergic polymorphic VT
- Wolff-Parkinson-White syndrome (WPW)
- Congenital short QT
- Hypertrophic Cardiomyopathy (HCM)
- Arrythmogenic RV dysplasia.
 
 
Reference:
Fischer JW, Cho CS. Pediatric syncope: cases from the emergency department. Emerg Med Clin North Am. 2010 Aug; 28(3):501-16.


Title: Pediatric intubation (submitted by Danya Khoujah, MBBS)

Category: Pediatrics

Keywords: premedication, RSI, ventilator, high flow nasal cannula (PubMed Search)

Posted: 9/21/2012 by Mimi Lu, MD
Click here to contact Mimi Lu, MD

When intubating an infant, a few key points need to be kept in mind:
- Remember that the narrowest point is the cricoid, so even if the ETT passes the cords it might still not pass through the cricoid itself.
- Remember premedication with atropine is recommended in all children less that 1 year old and in those less than 5 years old when using succinylcholine. It is used to prevent reflex bradycardia and high ICP and to decrease secretions. The dose is 0.02 mg/kg IV, with a minimum of 0.1 mg and a max of 0.5 mg. Give it 2 full minutes before the start of intubation.
- Remember that succinylcholine is contraindicated in neuromuscular disease (including an undiagnosed myopathy). A slightly higher dose (2mg/kg) may need to be used in infants (compared to 1-1.5mg/kg in adults and older children).  
- Pressure control mode is preferred over volume control (VC) setting in peds, because VC tends to overestimate how much volume it's delivering, therefore delivering inadequate ventilation.
- Remember your alternatives: High Flow Nasal cannula (HFNC) can be used in infants with respiratory distress to avoid intbation. One study showed that is decreased intubation rates by 68% in respiratory distress due to bronchiolitis
 
References:
1. Santillanes G, Gausche-Hill M. Pediatric Airway Management. Emerg Med Clin N Am 26 (2008) 961–975
2. Bledsoe G H, Schexnayder S M. Pediatric Rapid Sequence Intubation A Review. Ped Emerg Care 20 (2004) 339-344